Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Latanoprost in Ocular Hypertensive Patients
NCT01987323Phase 2Completed
- Sponsor
- Singapore Eye Research Institute
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of latanoprost in Glaucoma, ocular hypertension, sponsored by Singapore Eye Research Institute. Started Jan 2013; status: completed.
02
Drugs
latanoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01987323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987323.